These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38735175)

  • 1. Prognostic nomogram based on pre-treatment HALP score for patients with advanced non-small cell lung cancer.
    Gao S; Huang Q; Wei S; Lv Y; Xie Y; Hao Y
    Clinics (Sao Paulo); 2024; 79():100371. PubMed ID: 38735175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive nomogram for assessing the prognosis of non-small cell lung cancer patients receiving immunotherapy: a prospective cohort study in China.
    Li H; Yuan Y; Xu Q; Liang G; Hu Z; Li X; Zhang W; Lei H
    Front Immunol; 2024; 15():1487078. PubMed ID: 39635526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of efficacy and safety of PD-1/PD-L1 combination therapy in first-line treatment of advanced NSCLC: an updated systematic review and network meta-analysis.
    Yang Y; Chen W; Dong L; Duan L; Gao P
    Clin Transl Oncol; 2024 Oct; 26(10):2488-2502. PubMed ID: 38625495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Risk Factors, and Development and Validation of Prognostic Prediction Models for Distant Metastasis in Patients With Rectal Cancer: A Study Based on the SEER Database and a Chinese Population.
    Zhang H; Wang H; Yao Y; Liu L; Feng F; Li H; Sun C
    Cancer Control; 2024; 31():10732748241303650. PubMed ID: 39579008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analyzing HALP and PNI scores as prognostic factors in metastatic head and neck cancers.
    Duzkopru Y; Kocanoglu A; Yigitbay M; Dogan O; Sahinli H; Yazilitas D
    Asian J Surg; 2024 Dec; 47(12):5101-5105. PubMed ID: 38704268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the SORG Machine-learning Algorithm for Extremity Metastases Generalize to a Contemporary Cohort of Patients? Temporal Validation From 2016 to 2020.
    de Groot TM; Ramsey D; Groot OQ; Fourman M; Karhade AV; Twining PK; Berner EA; Fenn BP; Collins AK; Raskin K; Lozano S; Newman E; Ferrone M; Doornberg JN; Schwab JH
    Clin Orthop Relat Res; 2023 Dec; 481(12):2419-2430. PubMed ID: 37229565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a prognostic nomogram in patients aged ≥65 years with stage I-II non-small cell lung cancer treated with stereotactic body radiotherapy.
    Ji X; Zhou B; Huang H; Jiang W; Wang J; Ding W; Wang Z; Sun X
    J Geriatr Oncol; 2024 Nov; 15(8):102067. PubMed ID: 39288506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction nomogram based on 18F-FDG PET/CT and clinical parameters for patients with diffuse large B-cell lymphoma.
    Peng X; Yu S; Kou Y; Dang J; Wu P; Yao Y; Shen J; Liu Y; Wang X; Cheng Z
    Ann Hematol; 2023 Nov; 102(11):3115-3124. PubMed ID: 37400729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of natremia on metastatic non small cell lung cancer patients receiving immune checkpoint inhibitors.
    Catalano M; Fancelli S; Caliman E; Mazzoni F; Michelet MG; Mancini S; Manneschi C; Shabani S; Napolitano B; Pillozzi S; Antonuzzo L; Roviello G
    Sci Rep; 2024 Nov; 14(1):29655. PubMed ID: 39609621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of prognostic nutritional index on laboratory parameters and survival in metastatic colorectal cancer patients treated with fruquintinib: a retrospective study.
    Wang Z; Zhao S; Zhang X; Mao X; Yang G; Yuan M; Zhou X
    PeerJ; 2024; 12():e18565. PubMed ID: 39624124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Prognostic Values of Seven Immune Indexes in Advanced Non-Small-Cell Lung Cancer Treated with Nivolumab: How Effective Can They Be Regarding Our Treatment Decisions?
    Ulas A; Temel B; Kos FT
    Medicina (Kaunas); 2024 Nov; 60(11):. PubMed ID: 39596977
    [No Abstract]   [Full Text] [Related]  

  • 13. Aminotransferase-to-lymphocyte ratio as a valuable prognostic marker for patients with stage I-III colorectal cancer: a retrospective study.
    Xie H; Wei L; Tang S; Gan J
    Front Oncol; 2024; 14():1446557. PubMed ID: 39624626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periprostatic fat magnetic resonance imaging based radiomics nomogram for predicting biochemical recurrence-free survival in patients with non-metastatic prostate cancer after radical prostatectomy.
    Wu XH; Ke ZB; Chen ZJ; Liu WQ; Xue YT; Chen SH; Chen DN; Zheng QS; Xue XY; Wei Y; Xu N
    BMC Cancer; 2024 Nov; 24(1):1459. PubMed ID: 39604917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary lung tumour stereotactic body radiotherapy followed by concurrent mediastinal chemoradiotherapy and adjuvant immunotherapy for locally advanced non-small-cell lung cancer: a multicentre, single-arm, phase 2 trial.
    Heinzerling JH; Mileham KF; Robinson MM; Symanowski JT; Induru RR; Brouse GM; Corso CD; Prabhu RS; Haggstrom DE; Moeller BJ; Bobo WE; Fasola CE; Thakkar VV; Pal SE; Gregory JM; Norek SL; Begic XJ; Kesarwala AH; Burri SH; Simone CB
    Lancet Oncol; 2024 Nov; ():. PubMed ID: 39615497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world overview of therapeutic strategies and prognosis of older patients with advanced or metastatic non-small cell lung cancer from the ESME database.
    Cabart M; Mourey L; Pasquier D; Schneider S; Léna H; Girard N; Chouaid C; Schott R; Hiret S; Debieuvre D; Quantin X; Madroszyk A; Dubray-Longeras P; Pichon E; Baranzelli A; Justeau G; Pérol M; Bosquet L; Cabarrou B
    J Geriatr Oncol; 2024 Sep; 15(7):101819. PubMed ID: 39068144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of efficacy of different therapy regimens for advanced NSCLC patients with KRAS mutation in the first-line treatment.
    Wang K; Xu M; Wang Y; Xu C; Hao Y; Song Z
    Clin Transl Oncol; 2024 Oct; 26(10):2479-2487. PubMed ID: 38625494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of nomogram models for severe and fatal COVID-19.
    Chen J; Hu Q; Zhong R; Li L; Kang Y; Chen L; Huang R; You J
    Sci Rep; 2024 Nov; 14(1):29146. PubMed ID: 39587251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What Are the Functional, Radiographic, and Survivorship Outcomes of a Modified Cup-cage Technique for Pelvic Discontinuity?
    Mu W; Xu B; Wahafu T; Wang F; Guo W; Zou C; Cao L
    Clin Orthop Relat Res; 2024 Dec; 482(12):2149-2160. PubMed ID: 38991223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel staging system based on deep learning for overall survival in patients with esophageal squamous cell carcinoma.
    Zhang H; Jiang X; Yu Q; Yu H; Xu C
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8935-8944. PubMed ID: 37154930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.